Topical Agent for Treatment of Red Skin

• Status: Completed
• Trial end date: 2007-01-01

Summary

SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face to assess efficacy and safety

• Phase: Phase 1

Details

• Lead Sponsor: Mayo Clinic